Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2026-02-04 @ 6:30 PM
Study NCT ID:
NCT01941095
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2013-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-30
First Submit QC Date:
None
Study First Post Date:
2013-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-20
Results First Submit QC Date:
None
Results First Post Date:
2018-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-23
Last Update Post Date:
2018-11-13
Last Update Post Date Type:
ACTUAL